4
Changes in Ownership
Kymera Therapeutics, Inc. Filed Acc 0001209191-22-061706
10% owner sold 382,244 shares at an average $31.36 ($11,985,954)
From the SEC's structured data for this filing
Trades in this filing
Atlas Venture Fund X, L.P. · 10% owner
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-14 | Sale : show line 1 in the form | −112,819 | $30.28 | $3,416,159 | 5,252,744 | D |
| 2022-12-14 | Sale : show line 2 in the form | −101,189 | $31.44 | $3,181,382 | 5,151,555 | D |
| 2022-12-14 | Sale : show line 3 in the form | −54,737 | $32.33 | $1,769,647 | 5,096,818 | D |
| 2022-12-14 | Sale : show line 4 in the form | −13,997 | $33.34 | $466,660 | 5,082,821 | D |
| 2022-12-14 | Sale : show line 5 in the form | −13,335 | $34.02 | $453,657 | 5,069,486 | D |
| 2022-12-14 | Sale : show line 6 in the form | −31,584 | $30.28 | $956,364 | 969,833 | I |
| 2022-12-14 | Sale : show line 7 in the form | −28,329 | $31.44 | $890,664 | 941,504 | I |
| 2022-12-14 | Sale : show line 8 in the form | −15,324 | $32.33 | $495,425 | 926,180 | I |
| Open-market sales · 382,244 sh · avg $31.36 · $11,985,954 | ||||||
Loading xslF345X03/doc4.xml…